Menin is essential for the self-renewal of MN1-driven AML, and pharmacological inhibition of the MLL-menin interaction also has antiproliferative and differentiation-inducing effects in this AML variant when tested in experimental in vitro and xenograft models. This evidence concerns the gene MN1 and acute myeloid leukemia.